Abstract: Airborne transmitted pathogens, including severe acute respiratory coronavirus 2 (SARS-CoV-2) and similar infectious diseases, often spread through close contact between humans. One common form of transmission is that of saliva droplets that suspend in the air and are subsequently inhaled by another human, leading to pathogen transmission. The application is based on formulated confections (such as lozenges, cough drops, gum, candy, buccal films, and other consumable products) and/or medicinal drugs that alter fluid properties and/or reduce quantity of the saliva. As a result, the modified fluid properties of the saliva mitigates droplet breakup, resulting in larger droplets that travel shorter distances before quickly falling to a ground surface. The saliva reduction reduces the amount of saliva. As a result, the formulated confections reduce the prevalence of airborne transmitted pathogens (such as SARS-CoV-2) with a lesser/thickening saliva.